Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse

Neuropharmacology

Volumn 40, Issue 1, 2001, Pages 28-35

  Rogawski, Michael A ^a   Kurzman, Philip S ^a,b   Yamaguchi, Shun Ichi ^a   Li, He ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AMPA receptor; Amygdala; Kainate receptor; Kindling; Seizure

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; GLUTAMATE 5 RECEPTOR; GLUTAMATE RECEPTOR; KAINIC ACID RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; 6 (2 (1H TETRAZOL 5 YL)ETHYL) 1,2,3,4,4A,5,6,7,8,8A DECAHYDROISOQUINOLINE 3 CARBOXYLIC ACID; 6-(2-(1H-TETRAZOL-5-YL)ETHYL)-1,2,3,4,4A,5,6,7,8,8A-DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; ISOQUINOLINE DERIVATIVE; KAINIC ACID RECEPTOR; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 5; TETRAZOLE DERIVATIVE;

AFTERDISCHARGE; AMYGDALOID NUCLEUS; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ELECTROGRAPHY; EPILEPSY; EPILEPTOGENESIS; KINDLING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REBOUND; ANIMAL; DRUG ANTAGONISM; DRUG POTENTIATION; ELECTRODE; ELECTROSTIMULATION; PHYSIOLOGY;

AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; ISOQUINOLINES; KINDLING, NEUROLOGIC; MALE; MICE; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; RECEPTORS, METABOTROPIC GLUTAMATE; TETRAZOLES;

EID: 0035219751     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00112-X     Document Type: Article

References (31)

1. Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3 carboxylicacid
2. Pharmacological characterization of a GluR6 kainate receptor in cultured hippocampal neurons
3. Pretreatment but not posttreatment with GYKI 52466 reduces functional deficits and neuronal damage after global ischemia in rats
4. Kainate receptors are involved in synaptic plasticity
5. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice
6. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission
7. Excitatory amino acid receptors in the vertebrate central nervous system
8. 7-Chlorokynurenic acid, a strychnine-insensitive glycine receptor antagonist, inhibits limbic seizure kindling
9. The glutamate receptor ion channels
10. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses
11. The effect of the non-NMDA receptor antagonists GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures
12. The neuroprotective effects of the decahydroisoquinoline, LY 215490; a novel AMPA antagonist in focal ischaemia
13. A permanent change in brain function resulting from daily electrical stimulation
14. The N-methyl-d-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures
15. The role of NMDA receptors in epilepsy: I. Effects of NMDA receptor antagonists (CPP and MK-801) on amygdala kindling in rats
16. Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term potentiation in the rat
17. GluR5 kainate receptor mediated synaptic transmission in rat basolateral amygdala in vitro
18. Kainate receptor mediated heterosynaptic facilitation in the amygdala
19. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy
20. Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP
21. Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy
22. Decahydroisoquinolines: Novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia
23. (3SR,4aRS,6RS,8aRS)-6-[2-(1H-Tetrazol-5-yl)ethyl]decahydroisoquin oline-3-carboxylic acid: A structurally novel, systemically active, competitive AMPA receptor antagonist
24. Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons
25. Modification of seizure activity by electrical stimulation: II. Motor seizure
26. Excitatory amino acids and seizures
27. AMPA receptors in epilepsy and as targets for antiepileptic drugs
28. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy
29. In vitro and in vivo antagonism of AMPA receptor activation by (3S,4aR,8aR)-6-[2-(1(2)H-tetrazol-5-yl)ethyl]decahydroisoquinolin e-3-carboxylic acid
30. Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat
31. Anticonvulsant activity of AMPA/kainate antagonists: Comparison of GYKI 52466 and NBQX in maximal electroshock and chemoconvulsant seizure models